Caribou Biosciences (CRBU) Return on Sales (2020 - 2025)
Historic Return on Sales for Caribou Biosciences (CRBU) over the last 6 years, with Q3 2025 value amounting to 13.38%.
- Caribou Biosciences' Return on Sales rose 55200.0% to 13.38% in Q3 2025 from the same period last year, while for Sep 2025 it was 17.08%, marking a year-over-year decrease of 26900.0%. This contributed to the annual value of 14.92% for FY2024, which is 119600.0% down from last year.
- Caribou Biosciences' Return on Sales amounted to 13.38% in Q3 2025, which was up 55200.0% from 17.84% recorded in Q2 2025.
- In the past 5 years, Caribou Biosciences' Return on Sales ranged from a high of 0.62% in Q3 2023 and a low of 18.94% during Q1 2024
- Its 5-year average for Return on Sales is 10.99%, with a median of 8.89% in 2023.
- As far as peak fluctuations go, Caribou Biosciences' Return on Sales soared by 77200bps in 2021, and later plummeted by -182700bps in 2024.
- Quarter analysis of 5 years shows Caribou Biosciences' Return on Sales stood at 7.22% in 2021, then decreased by -15bps to 8.28% in 2022, then dropped by -27bps to 10.52% in 2023, then plummeted by -78bps to 18.72% in 2024, then increased by 29bps to 13.38% in 2025.
- Its Return on Sales stands at 13.38% for Q3 2025, versus 17.84% for Q2 2025 and 18.24% for Q1 2025.